Cyberonics' (CYBX) Revenue Growth Evaporates Amid NeuroPace, Preapproval Delays; BTIG Affirms at 'Neutral'

June 5, 2015 7:49 AM

BTIG affirms Cyberonics (Nasdaq: CYBX) with a Neutral rating following the company's Q1 report on Thursday night.Analyst Sean Lavin noted ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found